News

Stocks to buy in 2026 for long term: Saatvik Green, Tata Power among 4 stocks that could give 20-40% return

Brokerage Recommendations
Agencies
1/5
Brokerage Recommendations
Brokerages remain selectively bullish on stocks across sectors, identifying opportunities in power, pharmaceuticals, renewable energy and cement despite an uncertain macro environment.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
​Motilal Oswal on Saatvik Green Energy
ETMarkets.com
2/5
​Motilal Oswal on Saatvik Green Energy
Motilal Oswal on Saatvik Green Energy: Buy| Target Rs 565| LTP Rs 449| Potential Upside 26%

Motilal Oswal on Saatvik Green Energy: Motilal Oswal has initiated/maintained a 'Buy' rating on Saatvik Green Energy with a target price of Rs 565, implying a potential upside of nearly 26% from the current market price of Rs 449.
​Motilal Oswal on Tata Power​
Agencies
3/5
​Motilal Oswal on Tata Power​
Motilal Oswal on Tata Power Ltd: Buy| Target Rs 488| LTP Rs 378| Potential Upside 29%

Motilal Oswal on Tata Power: Motilal Oswal has maintained a 'Buy' rating on Tata Power with a target price of Rs 488, indicating a potential upside of around 29% from the current market price of Rs 378.
Amazon Top Deals
    ​Choice Institutional Equities on Nuvoco Vistas
    ETMarkets.com
    4/5
    ​Choice Institutional Equities on Nuvoco Vistas
    Choice Institutional Equities on Nuvoco Vistas Corporation: Buy| Target Rs 500| LTP Rs 341| Potential Upside 46%

    Choice Institutional Equities on Nuvoco Vistas Corporation: Choice Institutional Equities has assigned a 'Buy' rating to Nuvoco Vistas Corporation with a target price of Rs 500, suggesting a potential upside of approximately 46% from the current market price of Rs 341.
    ​Citi on Divi's Laboratories
    ETMarkets.com
    5/5
    ​Citi on Divi's Laboratories
    Citi on Divi's Laboratories Ltd: Buy| Target Rs 9450| LTP Rs 7185| Potential Upside 31%

    Citi on Divi's Laboratories: Citi has reiterated its 'Buy' rating on Divi's Laboratories with a target price of Rs 9,450, implying a potential upside of nearly 31% from the current market price of Rs 7,185.

    (Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
    Success
    This article has been saved